About Avedro, inc.
Avedro, Inc. is a leading medical technology company that specializes in developing and commercializing innovative products for the treatment of corneal disorders. The company was founded in 2002 and is headquartered in Waltham, Massachusetts.
Avedro's mission is to provide patients with safe and effective treatments that improve their quality of life. The company's flagship product, the KXL® System, is a non-invasive device that uses UV light to strengthen the cornea and treat conditions such as keratoconus and corneal ectasia.
In addition to its KXL® System, Avedro offers a range of other products for ophthalmic surgery and diagnostics. These include the Mosaic™ System for selective laser trabeculoplasty (SLT) glaucoma treatment, as well as diagnostic tools such as the Pentacam® HR Corneal Topography System.
Avedro has received numerous awards for its innovative products and commitment to patient care. In 2019, the company was named one of Boston's Best Places to Work by the Boston Business Journal.
One of Avedro's key strengths is its focus on research and development. The company invests heavily in clinical trials to ensure that its products are safe, effective, and meet regulatory requirements. This commitment has led to several FDA approvals for Avedro's devices over the years.
Another important aspect of Avedro's business model is its partnerships with leading ophthalmic surgeons around the world. These collaborations help ensure that Avedro's products are optimized for patient outcomes while also providing valuable feedback on product design and performance.
Overall, Avedro stands out among medical technology companies due to its dedication to innovation, patient care, research excellence, regulatory compliance,and strategic partnerships with top surgeons worldwide.Their relentless pursuit towards creating transformative therapies makes them an industry leader in treating glaucoma,corneal disorders,and retinal diseases which ultimately improves patients' quality of life significantly!